GlycoMimetics Inc (NASDAQ:GLYC) has a beta value of 1.82 and has seen 37.01 million shares traded in the recent trading session. The company, currently valued at $20.52M, closed the recent trade at $0.32 per share which meant it gained $0.03 on the day or 9.66% during that session. The GLYC stock price is -950.0% off its 52-week high price of $3.36 and 56.25% above the 52-week low of $0.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.46 million shares traded. The 3-month trading volume is 955.49K shares.
The consensus among analysts is that GlycoMimetics Inc (GLYC) is Hold stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
GlycoMimetics Inc (NASDAQ:GLYC) trade information
Sporting 9.66% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GLYC stock price touched $0.32 or saw a rise of 13.51%. Year-to-date, GlycoMimetics Inc shares have moved 27.71%, while the 5-day performance has seen it change 21.98%. Over the past 30 days, the shares of GlycoMimetics Inc (NASDAQ:GLYC) have changed 26.09%. Short interest in the company has seen 2.03 million shares shorted with days to cover at 5.97.
GlycoMimetics Inc (GLYC) estimates and forecasts
The company’s shares have gained 77.46% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 15.18% over the past 5 years.
GLYC Dividends
GlycoMimetics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Insiders own 2.86% of the company shares, while shares held by institutions stand at 47.16% with a share float percentage of 48.56%. Investors are also buoyed by the number of investors in a company, with GlycoMimetics Inc having a total of 47.0 institutions that hold shares in the company. The top two institutional holders are BVF INC/IL with over 9.54 million shares worth more than $2.69 million. As of 2024-06-30, BVF INC/IL held 14.8071% of shares outstanding.
The other major institutional holder is ARTAL GROUP S.A., with the holding of over 8.59 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.42 million and represent 13.3252% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 2.98% shares in the company for having 1.93 shares of worth $0.62 million while later fund manager owns 730.6 shares of worth $0.24 million as of Sep 30, 2024, which makes it owner of about 1.13% of company’s outstanding stock.
